← Evidence map

ReviewHeliyon2024

Application of combined ablation and immunotherapy in NSCLC and liver cancer: Current status and future prospects.

Jing-Shun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39253229